HNGE
Hinge Health·NYSE
--
--(--)
--
--(--)
HNGE fundamentals
During Q4 2025, Hinge Health (HNGE) reported revenue of 170.73M, a YoY change of 45.60%. Net income was 32.09M, a YoY change of 18.36%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 82.71M -- | 89.83M -- | 100.61M -- | 117.26M -- | 123.83M +49.71% | 139.10M +54.85% | 154.21M +53.27% | 170.73M +45.60% | 587.86M -- |
Sales and Services Revenue | 82.71M -- | 89.83M -- | 100.61M -- | 117.26M -- | 123.83M +49.71% | 139.10M +54.85% | 154.21M +53.27% | 170.73M +45.60% | 587.86M -- |
Cost of Revenue | 24.77M -- | 23.21M -- | 21.36M -- | 21.17M -- | 23.59M -4.75% | 41.34M +78.11% | 28.01M +31.15% | 26.70M +26.13% | 119.64M -- |
Cost of Goods and Services | 24.77M -- | 23.21M -- | 21.36M -- | 21.17M -- | 23.59M -4.75% | 41.34M +78.11% | 28.01M +31.15% | 26.70M +26.13% | 119.64M -- |
Gross Profit | 57.94M -- | 66.62M -- | 79.26M -- | 96.09M -- | 100.23M +72.99% | 97.76M +46.75% | 126.20M +59.23% | 144.03M +49.89% | 468.22M -- |
Operating Expenses | 89.36M -- | 84.17M -- | 83.10M -- | 75.18M -- | 87.10M -2.54% | 678.43M +706.05% | 132.29M +59.19% | 116.77M +55.33% | 1.01B -- |
Selling, General and Administrative Expenses | 59.60M -- | 59.25M -- | 59.32M -- | 52.81M -- | 63.60M +6.70% | 398.47M +572.55% | 100.37M +69.21% | 84.02M +59.10% | 646.46M -- |
Selling and Marketing Expenses | 42.14M -- | 44.89M -- | 44.57M -- | 35.45M -- | 46.72M +10.85% | 147.23M +227.95% | 63.52M +42.52% | 59.49M +67.80% | 316.95M -- |
General and Administrative Expenses | 17.46M -- | 14.35M -- | 14.75M -- | 17.36M -- | 16.88M -3.31% | 251.24M +1650.34% | 36.85M +149.89% | 24.53M +41.33% | 329.50M -- |
Research and Development Expenses | 29.76M -- | 24.92M -- | 23.79M -- | 22.37M -- | 23.50M -21.05% | 279.96M +1023.44% | 31.92M +34.21% | 32.76M +46.42% | 368.14M -- |
Operating Income | -31.42M -- | -17.55M -- | -3.85M -- | 20.91M -- | 13.14M +141.81% | -580.67M -3208.48% | -6.09M -58.47% | 27.26M +30.35% | -546.37M -- |
Non-Operating Income (Loss) | 5.12M -- | 4.99M -- | 5.29M -- | 5.25M -- | 5.00M -2.31% | 4.69M -5.86% | 4.46M -15.86% | 4.96M -5.59% | 19.11M -- |
Other Non-Operating Income (Loss) | 5.12M -- | 4.99M -- | 5.29M -- | 5.25M -- | 5.00M -2.31% | 4.69M -5.86% | 4.46M -15.86% | 4.96M -5.59% | 19.11M -- |
Pretax Income From Continuing Operations | -26.31M -- | -12.56M -- | 1.45M -- | 26.16M -- | 18.14M +168.95% | -575.98M -4483.98% | -1.64M -212.97% | 32.22M +23.13% | -527.26M -- |
Income Tax Expense | 158.00K -- | 361.00K -- | 1.11M -- | -951.00K -- | 998.00K +531.65% | -326.00K -190.30% | 206.00K -81.42% | 122.00K +112.83% | 1.00M -- |
Net Income | -26.46M -- | -12.93M -- | 341.00K -- | 27.12M -- | 17.14M +164.76% | -575.65M -4353.43% | -1.84M -640.76% | 32.09M +18.36% | -528.26M -- |
Net Income Attributable to Owners of the Company | -26.46M -- | -12.93M -- | 341.00K -- | 27.12M -- | 17.14M +164.76% | -575.65M -4353.43% | -1.84M -640.76% | 32.09M +18.36% | -528.26M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -104.17M -- | -- -- |
Other Adjustments | 0 -- | 0 -- | 269.00K -- | 0 -- | -104.17M -- | 0 -- | 0 -100.00% | 104.17M -- | -- -- |
Net Income Attributable to Common Stockholders | -26.46M -- | -12.93M -- | 72.00K -- | 27.12M -- | 121.31M +558.41% | -575.65M -4353.43% | -1.84M -2661.11% | 32.09M +18.36% | -424.09M -- |
Other Comprehensive Income | -105.00K -- | -11.00K -- | 261.00K -- | -137.00K -- | -58.00K +44.76% | -44.00K -300.00% | 87.00K -66.67% | -73.00K +46.72% | -88.00K -- |
Total Comprehensive Income | -26.57M -- | -12.94M -- | 602.00K -- | 26.98M -- | 17.08M +164.29% | -575.70M -4349.99% | -1.76M -391.86% | 32.02M +18.69% | -528.35M -- |
Total Comprehensive Income Attributable to Owners of the Company | -26.57M -- | -12.94M -- | 602.00K -- | 26.98M -- | 17.08M +164.29% | -575.70M -4349.99% | -1.76M -391.86% | 32.02M +18.69% | -528.35M -- |
Basic EPS | -1.98 -- | -0.96 -- | 0.01 -- | -- -- | 7.91 +499.49% | -13.1 -1264.58% | -0.02 -300.00% | 0.41 -- | -4.8 -- |
Basic EPS from Continuing Operations | -1.98 -- | -0.96 -- | 0.01 -- | -- -- | 7.91 +499.49% | -13.1 -1264.58% | -0.02 -300.00% | -- -- | -- -- |
Diluted EPS | -1.98 -- | -0.96 -- | 0.01 -- | -- -- | 1.31 +166.16% | -13.1 -1264.58% | -0.02 -300.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -1.98 -- | -0.96 -- | 0.01 -- | -- -- | 1.31 +166.16% | -13.1 -1264.58% | -0.02 -300.00% | -- -- | -- -- |
You can ask Aime
What factors drove the changes in Hinge Health's revenue and profit?What is the revenue and EPS growth rate for Hinge Health year over year?What is Hinge Health's latest dividend and current dividend yield?What guidance did Hinge Health's management provide for the next earnings period?What were the key takeaways from Hinge Health’s earnings call?What is the market's earnings forecast for Hinge Health next quarter?What does Hinge Health do and what are its main business segments?What were the key takeaways from Hinge Health's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
